Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 2, 2010, Pages 837-846

  Marshall, Aaron M ^a   Nommsen Rivers, Laurie A ^b   Hernandez, Laura L ^a   Dewey, Kathryn G ^c   Chantry, Caroline J ^d   Gregerson, Karen A ^a   Horseman, Nelson D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MONOAMINE OXIDASE INHIBITOR; OCCLUDIN; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INVOLUTION; KNOCKOUT MOUSE; LACTATION; MAMMARY GLAND; MORPHOLOGY; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; SEROTONIN METABOLISM;

ANIMALIA; MUS;

EID: 76149139405     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1575     Document Type: Article

References (47)

1. Schwarz EB, Ray RM, Stuebe AM, Allison MA, Ness RB, Freiberg MS, Cauley JA 2009 Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol 113:974-982
2. Gunderson EP, Lewis CE, Wei GS, Whitmer RA, Quesenberry CP, Sidney S 2007 Lactation and changes in maternal metabolic risk factors. Obstet Gynecol 109:729-738
3. Oddy WH, Peat JK 2003 Breastfeeding, asthma, and atopic disease: an epidemiological review of the literature. J Hum Lact 19:250-261; quiz 262-266
4. Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, Trikalinos T, Lau J 2007 Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 153:1-186
5. World Health Organization 2001 Report of the expert consultation of the optimal duration of exclusive breastfeeding. Geneva: World Health Organization
6. Wright HJ, Walker PC 1983 Prediction of duration of breast feeding in primiparas. J Epidemiol Community Health 37:89-94
7. Chapman DJ, Perez-Escamilla R 1999 Does delayed perception of the onset of lactation shorten breastfeeding duration? J Hum Lact 15:107-111; quiz 137-139
8. McLeod D, Pullon S, Cookson T 2002 Factors influencing continuation of breastfeeding in a cohort of women. J Hum Lact 18:335-343
9. Cernadas JM, Noceda G, Barrera L, Martinez AM, Garsd A 2003 Maternal and perinatal factors influencing the duration of exclusive breastfeeding during the first 6 months of life. J Hum Lact 19:136-144
10. Hurst NM 2007 Recognizing and treating delayed or failed lactogenesis II. J Midwifery Womens Health 52:588-594
11. Dewey KG, Nommsen-Rivers LA, Heinig MJ, Cohen RJ 2003 Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics 112:607-619
12. Pang WW, Hartmann PE 2007 Initiation of human lactation: Secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia 12:211-221
13. Hruschka DJ, Sellen DW, Stein AD, Martorell R 2003 Delayed onset of lactation and risk of ending full breast-feeding early in rural Guatemala. J Nutr 133:2592-2599
14. Nommsen-Rivers LA, Mastergeorge AM, Hansen RL, Cullum AS, Dewey KG 2009 Doula care, early breastfeeding outcomes, and breastfeeding status at 6 weeks postpartum among low-income primiparae. J Obstet Gynecol Neonatal Nurs 38:157-173
15. Nguyen DA, Neville MC 1998 Tight junction regulation in the mammary gland. J Mammary Gland Biol Neoplasia 3:233-246
16. Alexander CM, Selvarajan S, Mudgett J, Werb Z 2001 Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 152:693-703
17. Stein T, Salomonis N, Gusterson BA 2007 Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 12:25-35
18. Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM,Walther DJ, Bader M, Horseman ND2004 Serotonin regulates mammary gland development via an autocrineparacrine loop. Dev Cell 6:193-203
19. Stull MA, Pai V, Vomachka AJ, Marshall AM, Jacob GA, Horseman ND 2007 Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci USA 104: 16708-16713
20. Pai VP, Horseman ND 2008 Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways. J Biol Chem 283:30901-30910
21. Marshall AM, Pai VP, Sartor MA, Horseman ND 2009 In vitro multipotent differentiation and barrier function of a human mammary epithelium. Cell Tissue Res 335:383-395
22. Hernandez LL, Stiening CM, Wheelock JB, Baumgard LH, Parkhurst AM, Collier RJ 2008 Evaluation of serotonin as a feedback inhibitor of lactation in the bovine. J Dairy Sci 91:1834-1844
23. Silberstein GB, Daniel CW 2000 Slow-release plastic pellets (elvax) for localized in situ treatments of mouse and rat mammary tissue. In: Ip MM, Asch BB, eds. Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic/Plenum Publishers; 87
24. Ip MM, Asch BB 2000 Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic/Plenum Publishers; 329
25. Stiening CM, Hoying JB, Abdallah MB, Hoying AM, Pandey R, Greer K, Collier RJ 2008 The effects of endocrine and mechanical stimulation on stage I lactogenesis in bovine mammary epithelial cells. J Dairy Sci 91:1053-1066
26. Nommsen-Rivers LA, Dewey KG 2009 Development and validation of the infant feeding intentions scale. Matern Child Health J 13:334-342
27. Matthews MK 1993 Assessments and suggested interventions to assist newborn breastfeeding behavior. J Hum Lact 9:243-248
28. Daniel CW, Silberstein GB, Strickland P 1987 Direct action of 17 β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47:6052-6057
29. Adler RA 1986 The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia. Endocr Rev 7:302-313
30. Tobon H, Salazar H 1975 Ultrastructure of the human mammary gland. II. Postpartum lactogenesis. J Clin Endocrinol Metab 40: 834-844
31. Nguyen DA, Parlow AF, Neville MC 2001 Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 170:347-356
32. Dewey KG, Nommsen-Rivers L, Cohen RJ, Chantry CJ, Peerson JM 2009 Delayed lactogenesis and excess neonatal weight loss are common across ethnic and socioeconomic categories of primiparous women in northern California. FASEB J 23:344.7 (Meeting Abstracts)
33. Nommsen-Rivers LA, Cohen RJ, Chantry CJ, Peerson JM, Dewey KG 2009 Risk factors for delayed onset of lactogenesis among northern California primiparous women. FASEB J 23:344.8 (Meeting Abstracts)
34. Roberts RE, Vernon SW 1983 The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 140:41-46
35. Stafford RS, MacDonald EA, Finkelstein SN 2001 National patterns of medication treatment for depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry 3:232-235
36. Kä llén BA, Otterblad Olausson P 2007 Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79: 301-308
37. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM, National Birth Defects Prevention Study 2007 Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684-2692
38. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA 2007 First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675-2683
39. Gentile S, Rossi A, Bellantuono C 2007 SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Arch Womens Ment Health 10:39-51
40. Nielsen RE, Stage KB, Christensen PM, Mortensen S, Andersen LL, Damkier P 2007 Medical treatment of depression during pregnancy and breastfeeding. Ugeskr Laeger 169:1442-1444
41. Gentile S 2007 Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 30:107-121
42. Agut-Quijano T, Martínez-Nadal S, Elizari-Saco MJ, Sala-Castellví P, Vila-Cerén C, Raspall-Torrent F 2006 Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review. Rev Neurol 42:660-662
43. Funk DA, Freeman AE, Berger PJ 1982 Environmental and physiological factors affecting mastitis at drying off and postcalving. J Dairy Sci 65:1258-1268
44. Dingwell RT, Duffield TF, Leslie KE, Keefe GP, DesCoteaux L, Kelton DF, Lissemore KD, Schukken YH, Dick P, Bagg R 2002 The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period. J Dairy Sci 85:3250-3259
45. Eberhart RJ 1986 Management of dry cows to reduce mastitis. J Dairy Sci 69:1721-1732
46. Betzold CM 2007 An update on the recognition and management of lactational breast inflammation. J Midwifery Womens Health 52:595-605
47. Kasonka L, Filteau S, Breast-Feeding and Postpartum Health Project Team 2009 Exclusive breast-feeding and HIV infection. Adv Exp Med Biol 639:291-298